These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 16546761)

  • 41. A4T mutation in the SOD1 gene causing familial amyotrophic lateral sclerosis.
    Aksoy H; Dean G; Elian M; Deng HX; Deng G; Juneja T; Storey E; McKinlay Gardner RJ; Jacob RL; Laing NG; Siddique T
    Neuroepidemiology; 2003; 22(4):235-8. PubMed ID: 12792143
    [TBL] [Abstract][Full Text] [Related]  

  • 42. MRI detects early hindlimb muscle atrophy in Gly93Ala superoxide dismutase-1 (G93A SOD1) transgenic mice, an animal model of familial amyotrophic lateral sclerosis.
    Brooks KJ; Hill MD; Hockings PD; Reid DG
    NMR Biomed; 2004 Feb; 17(1):28-32. PubMed ID: 15011248
    [TBL] [Abstract][Full Text] [Related]  

  • 43. [From gene to disease: amyotrophic lateral sclerosis].
    van Vught PW; Veldink JH; Baas F; van Muiswinkel FL; van den Berg LH
    Ned Tijdschr Geneeskd; 2004 Oct; 148(43):2125-7. PubMed ID: 15553356
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Mutational analysis of the Cu/Zn superoxide dismutase gene in 23 familial and 69 sporadic cases of amyotrophic lateral sclerosis in Belgium.
    Aguirre T; Matthijs G; Robberecht W; Tilkin P; Cassiman JJ
    Eur J Hum Genet; 1999 Jul; 7(5):599-602. PubMed ID: 10439968
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Rapid disease progression correlates with instability of mutant SOD1 in familial ALS.
    Sato T; Nakanishi T; Yamamoto Y; Andersen PM; Ogawa Y; Fukada K; Zhou Z; Aoike F; Sugai F; Nagano S; Hirata S; Ogawa M; Nakano R; Ohi T; Kato T; Nakagawa M; Hamasaki T; Shimizu A; Sakoda S
    Neurology; 2005 Dec; 65(12):1954-7. PubMed ID: 16291929
    [TBL] [Abstract][Full Text] [Related]  

  • 46. [Clinical features and neuropathological findings of familial amyotrophic lateral sclerosis with an H43R mutation in Cu/Zn superoxide dismutase].
    Mochizuki Y; Mizutani T; Nakano R; Fukushima T; Honma T; Nemoto N; Takei K
    Rinsho Shinkeigaku; 2003 Aug; 43(8):491-5. PubMed ID: 14658402
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Increased affinity for copper mediated by cysteine 111 in forms of mutant superoxide dismutase 1 linked to amyotrophic lateral sclerosis.
    Watanabe S; Nagano S; Duce J; Kiaei M; Li QX; Tucker SM; Tiwari A; Brown RH; Beal MF; Hayward LJ; Culotta VC; Yoshihara S; Sakoda S; Bush AI
    Free Radic Biol Med; 2007 May; 42(10):1534-42. PubMed ID: 17448900
    [TBL] [Abstract][Full Text] [Related]  

  • 48. SOD1 A4V familial ALS in North America: can understanding the past lead to a better future?
    Armon C
    Neurology; 2009 May; 72(19):1628-9. PubMed ID: 19176894
    [No Abstract]   [Full Text] [Related]  

  • 49. Screening of VCP mutations in Chinese amyotrophic lateral sclerosis patients.
    Zou ZY; Liu MS; Li XG; Cui LY
    Neurobiol Aging; 2013 May; 34(5):1519.e3-4. PubMed ID: 23102936
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Sporadic amyotrophic lateral sclerosis and breast cancer: Hyaline conglomerate inclusions lead to identification of SOD1 mutation.
    Hays AP; Naini A; He CZ; Mitsumoto H; Rowland LP
    J Neurol Sci; 2006 Mar; 242(1-2):67-9. PubMed ID: 16423367
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Clinical features and Cu/Zn superoxide dismutase gene mutations in two mainland Chinese families with amyotrophic lateral sclerosis.
    Zhao G; Yin X; Wu D; Mao S; Yin H; Zhang B
    Int J Neurosci; 2011 Apr; 121(4):191-5. PubMed ID: 21329474
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Cerebrospinal fluid neurofilament light levels in amyotrophic lateral sclerosis: impact of SOD1 genotype.
    Zetterberg H; Jacobsson J; Rosengren L; Blennow K; Andersen PM
    Eur J Neurol; 2007 Dec; 14(12):1329-33. PubMed ID: 17903209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. An epigenetic analysis of SOD1 and VEGF in ALS.
    Oates N; Pamphlett R
    Amyotroph Lateral Scler; 2007 Apr; 8(2):83-6. PubMed ID: 17453634
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Corticomotoneuronal dysfunction in ALS patients with different SOD1 mutations.
    Stewart HG; Andersen PM; Eisen A; Weber M
    Clin Neurophysiol; 2006 Aug; 117(8):1850-61. PubMed ID: 16793335
    [TBL] [Abstract][Full Text] [Related]  

  • 55. The IVS1 +319 t>a of SOD1 gene is not an ALS causing mutation.
    Restagno G; Gomez A; Lombardo F; Cocco E; Calvo A; Ghiglione P; Mutani R; Chiò A
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2005 Mar; 6(1):45-9. PubMed ID: 16036425
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Genetic markers of ALS.
    Robberecht W
    Amyotroph Lateral Scler Other Motor Neuron Disord; 2000 Jun; 1 Suppl 2():S57-9. PubMed ID: 11464943
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Proposed criteria for familial amyotrophic lateral sclerosis.
    Byrne S; Bede P; Elamin M; Kenna K; Lynch C; McLaughlin R; Hardiman O
    Amyotroph Lateral Scler; 2011 May; 12(3):157-9. PubMed ID: 21208036
    [No Abstract]   [Full Text] [Related]  

  • 58. [Basic and clinical researches on amyotrophic lateral sclerosis/motor neuron disease].
    Fan DS; Zhang J; Deng M; Kang DX; Zheng JY; Xu YS; Lu M; Fu Y; Shen Y; Zhang YS; Zhang HG
    Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Jun; 41(3):279-81. PubMed ID: 19727208
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Clinical presentation and diagnosis of amyotrophic lateral sclerosis.
    Ferguson TA; Elman LB
    NeuroRehabilitation; 2007; 22(6):409-16. PubMed ID: 18198425
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Racing against the clock: recognizing, differentiating, diagnosing, and referring the amyotrophic lateral sclerosis patient.
    Shook SJ; Pioro EP
    Ann Neurol; 2009 Jan; 65 Suppl 1():S10-6. PubMed ID: 19191305
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.